Direkt zum Inhalt
Merck

A simple protocol to produce mature human-induced pluripotent stem cell-derived cardiomyocytes.

STAR protocols (2021-11-11)
Walter E Knight, Yingqiong Cao, Phoebe Dillon, Kunhua Song
ZUSAMMENFASSUNG

When cultured under typical conditions, human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are structurally and functionally immature. We have previously demonstrated that culture of hiPSC-CMs in maturation medium containing fatty acids, in combination with culture on micropatterned surfaces, produces cells that demonstrate a more mature phenotype compared to standard approaches. Here, we show in detail the steps needed to produce mature hiPSC-CMs. Compared with many approaches, our protocol is relatively simple and can be easily adapted to new laboratories. For complete details on the use and execution of this protocol, please refer to Knight et al. (2021).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Saccharose, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
Proteasehemmer-Cocktail, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
MOPS, ≥99.5% (titration)
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Gelatine aus Schweinehaut, gel strength 300, Type A
Sigma-Aldrich
Harnstoff, ACS reagent, 99.0-100.5%
Sigma-Aldrich
Monoklonales Anti-α-Aktinin (Sarkomer) in Maus hergestellte Antikörper, clone EA-53, ascites fluid
Sigma-Aldrich
Kaliumhydroxid, BioXtra, ≥85% KOH basis
Millipore
EDTA, ULTROL® Grade, 500 mM Solution, pH 8.0
Sigma-Aldrich
Ethylenglykol-bis(2-aminoethylether)-N,N,N′,N′-Tetraessigsäure, ≥97.0%